Wearable device

Wearable device has been studied in 82 papers since 2017: 4 trials and 24 observational studies in people, 38 reviews; 43 in the past year. The newest paper, Oct 23, 2026: “Comparative Efficacy of eHealth-Based Interventions for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis”.

Intervention

82 papers study it28 findingsUpdated

1 new paper in 30 daysSee all 82 papers on wearable device

At a glance

Independent labs found the same change in people. 17 independent labs in 11 countries.

“the change in physical activity was significantly greater in patients with a wearable watch than in those with usual care”
Integration of Wearables Into a Cardiac Rehabilitation Program and Its Impact on Physical Activity and Exercise Capacity in Older Patients With Cardiovascular DiseaseAdvances in rehabilitation science and practice2025doi:10.1177/27536351251343538

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 17 independent labs in 11 countries
  • Funders: National Institute for Health Research and others
  • 6 of 25 findings with company ties
  • Human trial4
  • Humans24
  • In silico4

Studies in people

1 study gave wearable device to people and measured what changed.

What changedDesignPeopleSource

up: Increases physical activity2073 [1155-4400] vs 148 [−1261-899] METs-minute/week

up: Improves physical function

Randomized trial12 weeks39 people82% menmedian age = 73 years, interquartile range = 68-78 yearsPatients aged 60 years or older with cardiovascular diseaseAdvances in rehabilitation science and practice, May 30, 2025

What did studies of wearable device find?

8

Studies of wearable device measured 8 outcomes, among them physical activity, heart failure hospitalization and atrial fibrillation detection.

Physical activity

upin humans2

2 studies
  1. Wearable device increases physical activity in humans (2073 [1155-4400] vs 148 [−1261-899] METs-minute/week).

    “The change in total physical activity was significantly greater in patients with a wearable watch than in those with usual care (median: 2073 [1155-4400] vs 148 [−1261-899] METs-minute/week; ANCOVA P <.001; ).”

    Human trial12 weeksn = 39

    Integration of Wearables Into a Cardiac Rehabilitation Program and Its Impact on Physical Activity and Exercise Capacity in Older Patients With Cardiovascular Disease

    Advances in rehabilitation science and practice

  2. Wearable device increases physical activity in humans (older patients with cardiovascular disease) (median: 2073 [1155-4400] vs 148 [-1261-899] METs-minute/week; P < .001).

    “the change in physical activity was significantly greater in patients with a wearable watch than in those with usual care”

    Human trialolder patients with cardiovascular disease12 weeks82% mensn = 39

    Integration of Wearables Into a Cardiac Rehabilitation Program and Its Impact on Physical Activity and Exercise Capacity in Older Patients With Cardiovascular Disease

    Advances in rehabilitation science and practice

  3. Wearable device improves physical activity in humans (small-to-medium effect).

    “The use of wearable devices as interventions had a small-to-medium effect on increasing physical activity and daily steps.”

    Review

    Physical activity interventions for older adults - an overview of systematic reviews

    BMC public health

Heart failure hospitalization

downin humans1

1 study
  1. Wearable device decreases heart failure hospitalization in structured programs (reductions in heart-failure hospitalization of 18-32%).

    “structured heart-failure telemonitoring, associated with reductions in heart-failure hospitalization of 18-32% in structured programs”

    Reviewin structured programs

    Wearable Devices in Cardiovascular Care: A Narrative Review of the Transition Toward Predictive, Preventive, Personalized, and Participatory Medicine

    Healthcare (Basel, Switzerland)

More on Heart failure hospitalization

Atrial fibrillation detection

upin humans1

1 study
  1. Wearable device improves atrial fibrillation detection in humans.

    “Contemporary wearable devices utilizing photoplethysmography and mobile ECG have demonstrated high positive predictive values for AF detection in large-scale studies”

    Review

    WERABLE TECHNOLOGIES IN ATRIAL FIBRILLATION SCREENING: A NARRATIVE REVIEW

    International Journal of Innovative Technologies in Social Science

Mortality

downin humans1RR 0.49

1 study
  1. Wearable device decreases mortality in humans (patients with atrial fibrillation) (RR 0.49, 95% CI 0.29-0.85).

    “all-cause mortality (RR, 0.49; 95% CI, 0.29-0.85)”

    Reviewpatients with atrial fibrillation

    Wearable device monitoring reduces the MACEs in patients with atrial fibrillation: A systematic review and meta-analysis

    Journal of telemedicine and telecare

Diagnostic accuracy

upin humans1

1 study
  1. Wearable device improves diagnostic accuracy in humans (for AF detection) (sensitivity and specificity frequently 90–97%).

    “achieve high diagnostic accuracy for AF detection (sensitivity and specificity frequently 90–97%)”

    Reviewfor AF detection

    Fitness Trackers and Other Wearable Devices in Cardiology for Prevention, Screening and Diagnosis of Arrhythmias: Focus on Atrial Fibrillation

    Quality in Sport

More on Diagnostic accuracy

Waist circumference

downin humans1

1 study
  1. Wearable device decreases waist circumference in humans (overweight or obesity) (MD -5.22 cm, 95% CI -9.03 to -1.40).

    “In adults, waist circumference decreased significantly (MD, -5.22 cm; 95% CI, -9.03 to -1.40; P = 0.007)”

    Reviewoverweight or obesity

    Differential effects of wearable device-based interventions on weight and health outcomes in adults and youth with overweight or obesity: A systematic review and meta-analysis

    Digital health

More on Waist circumference

BMI

downin humans1

1 study
  1. Wearable device decreases BMI in humans (overweight or obesity) (MD -0.63 kg/m2, 95% CI -1.01 to -0.25).

    “Wearable device interventions significantly reduced BMI overall (mean difference [MD], -0.63 kg/m2; 95% confidence interval [CI], -1.01 to -0.25; P = 0.001)”

    Reviewoverweight or obesity

    Differential effects of wearable device-based interventions on weight and health outcomes in adults and youth with overweight or obesity: A systematic review and meta-analysis

    Digital health

More on BMI

Physical function

upin humans1

1 study
  1. Wearable device improves physical function in humans.

    “The change in the anaerobic threshold was significantly improved in patients with a wearable watch compared with those with usual care (P <.01).”

    Human trial12 weeksn = 39

    Integration of Wearables Into a Cardiac Rehabilitation Program and Its Impact on Physical Activity and Exercise Capacity in Older Patients With Cardiovascular Disease

    Advances in rehabilitation science and practice

What is wearable device linked with?

18

Studies link wearable device with 18 measures, among them heart failure, construct validity and diabetes detection.

Heart failure

upin humans1+87% sensitivity

1 study
  1. Wearable device predicts heart failure in humans (heart failure) (87% sensitivity).

    “The LINK-HF study predicted HF hospitalization with 87% sensitivity up to six days in advance.”

    Reviewheart failure

    WEARABLE TECHNOLOGIES IN CARDIOVASCULAR RISK MONITORING: A LITERATURE REVIEW OF CLINICAL EVIDENCE

    International Journal of Innovative Technologies in Social Science

More on Heart failure

Construct validity

upin humans1

1 study
  1. Wearable device is associated with construct validity in humans (non-acute proximal femoral fracture (≥ 15 days since surgery)) (17 of 24 DMOs).

    “17 of 24 DMOs showing evidence of construct validity in non-acute PFF patients.”

    Humansnon-acute proximal femoral fracture (≥ 15 days since surgery)seven daysn = 505

    Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study

    Scientific reports

Diabetes detection

upin humans1

1 study
  1. Wearable device predicts diabetes detection in humans (0.88 AUROC, 0.80 AUPRC).

    “with the best algorithm (21-nights) achieving 0.88 Area under ROC (AUROC) and 0.80 Area under Precision Recall (AUPRC)”

    Humans21-nights

    Sleep and temperature data from wearable devices support noninvasive detection of diabetes mellitus in a large-scale, retrospective analysis

    Communications medicine

Insulin resistance

upin humans1

1 study
  1. Wearable device predicts insulin resistance in humans (HOMA-IR cut-off of 2.9) (AUROC = 0.80, sensitivity = 76%, specificity = 84%).

    “our multimodal model achieved robust performance (area under the receiver operating characteristic curve (AUROC) = 0.80, sensitivity = 76%, specificity = 84%)”

    HumansHOMA-IR cut-off of 2.9n = 1,165

    Insulin resistance prediction from wearables and routine blood biomarkers

    Nature

More on Insulin resistance

Ischemic stroke

downin humans1RR 0.13

1 study
  1. Wearable device lowers the risk of ischemic stroke in humans (patients with atrial fibrillation) (RR 0.13, 95% CI 0.07-0.26).

    “ischemic stroke (RR, 0.13; 95% CI, 0.07-0.26)”

    Reviewpatients with atrial fibrillation

    Wearable device monitoring reduces the MACEs in patients with atrial fibrillation: A systematic review and meta-analysis

    Journal of telemedicine and telecare

More on Ischemic stroke

Major adverse cardiovascular events

downin humans1RR 0.66

1 study
  1. Wearable device lowers the risk of major adverse cardiovascular events in humans (patients with atrial fibrillation) (RR 0.66, 95% CI 0.47-0.93).

    “wearable devices uses significantly reduced risks of MACEs (risk ratio [RR], 0.66; 95% confidence interval [CI], 0.47-0.93)”

    Reviewpatients with atrial fibrillation

    Wearable device monitoring reduces the MACEs in patients with atrial fibrillation: A systematic review and meta-analysis

    Journal of telemedicine and telecare

Prodromal Parkinson's disease

upin humans1

1 study
  1. Wearable device predicts prodromal Parkinson's disease in humans (prodromal Parkinson's disease).

    “digital biomarkers based on wearable or portable devices have gradually been applied to identify populations at risk for pPD.”

    Reviewprodromal Parkinson's disease

    Digital Biomarkers Based on Wearable or Portable Devices for Identifying Prodromal Parkinson's disease: A Scoping Review

    Preprint

More on Prodromal Parkinson's disease

Cardiovascular disease

upin humans1

1 study
  1. Wearable device predicts cardiovascular disease in women.

    “Cardiovascular risk stratification showed promising results, though external validation was rare.”

    Reviewin women

    Non-invasive blood pressure monitoring using wearables for cardiovascular risk assessment: a systematic review

    Archives of gynecology and obstetrics

More on Cardiovascular disease

Blood pressure

mixedin humans1

1 study
  1. Wearable device is associated with blood pressure in humans (validation against gold-standard BP methods).

    “Accuracy was moderate to high for diastolic blood pressure, but systolic blood pressure showed greater variability.”

    Reviewvalidation against gold-standard BP methods

    Non-invasive blood pressure monitoring using wearables for cardiovascular risk assessment: a systematic review

    Archives of gynecology and obstetrics

More on Blood pressure

Atherosclerotic cardiovascular disease risk category

upin humans1

1 study
  1. Wearable device predicts atherosclerotic cardiovascular disease risk category in humans (AUC 0.95, 77% sensitivity, 95% specificity).

    “A wearable-based model with demographics predicted the ASCVD risk category (≥7.5% vs. <7.5% risk per PREVENT) with an AUC 0.95, 77% sensitivity, and 95% specificity (Table 2).”

    Humansmedian follow-up of 4.1 years74% femalesn = 4,193

    From Wrist to Risk: Advancing Cardiovascular Prediction Using Wearables

    AHA Scientific Sessions 2025 abstract

All 18

Funding

7 grants since 2016

Japan Society for the Promotion of Science¥37.8MNational Institute of Diabetes and Digestive and Kidney Diseases$490KNational Institute on Aging$223K

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 3Jan 2026: 7Feb 2026: 4Mar 2026: 13Apr 2026: 2May 2026: 2Jun 2026: 4Jul 2026: 5Aug 2026: 1Sep 2026: 1Oct 2026: 1Nov 2026: 043 papers in 12 months

See all 82 papers on wearable device